5Oehler MK,Fung A,Jobling TW.Advances in the treatment of endometrial cancer[J].J Br Menopause Soc,2005,11 (1):18-22.
6Plante M,Renaud MC,Francois H,et al.Vaginal radical trachelectomy:an oncologically safe fertility-preserving surgery.An updated series of 72 cases and review of the literature[J].Gynecol Oncol,2004,94 (3):614-623.
3[2]Brewster WR, DiSaia PJ, Monk BJ, et al. Young age as a prognostic factor in cervical cancer: results of a population - based study [ J] . Am J Obstet Gynecol, 1999; 1: 1464 - 1467
4[3]Acharki A, Sahraoui S, Benider A, et al. Cancer of the uterine cervix in young women. A retrospective study of 337 cases [ J ] . Bull Cancer,1997, 84; 4:373-378
5[1]Takizawa K, yokoo I, Shima Y, et al. Quantitative evaluation for murine oocyte toxicity following intraperitoneal treatment with chemotherapeutic agents. Acta Obst Gynec Jpn. 1989, 41: 715- 722
6[2]Koyama H, Wada T, Nishizawa Y, et al. Cyclophosphamide- induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer, 1977, 39: 1403-1409
7[3]Fisher B, Sherman B, Rockette H, et al.L- phenylalanine mustard (L- PAN) in the management of premenopausal patients with primary breast cancer. Cancer, 1979, 44:847-857
8[4]Nasiry J, Walton C, Lindow SW, et al. Spontaneous recovery of chemotherapy- induced primary ovarian failure: implication for management.Clin Endocrinol, 1997, 46:217-219
9[5]Blumenfeld Z, Nissim H. Prevention of gonadal damage during cytotoxic therapy. Ann Med. 1997, 29: 199- 206
10[6]Feldman JE. Ovarian failure and cancer treatment - Incidence and interventions for the premenopausal women. Oncol Nurs Forum. 1989, 16:651
